Zinc L-carnosine complex polaprezinc for pica and polydipsia
Not Applicable
- Conditions
- Pica and polydipsia
- Registration Number
- JPRN-UMIN000016738
- Lead Sponsor
- Department of Public Health and Environmental Medicine, The Jikei University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
1) Malignant tumor 2) Chronic renal failure (estimated glomerular filtration rate, eGFR <45) 3) Other severe diseases 4) Terminal phase of an illness 5) History of taking polaprezinc or other zinc supplementation
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Frequency of pica
- Secondary Outcome Measures
Name Time Method Severity of polydipsia assessed by diurnal weight gain and blood concentration of sodium Serum concentrations of BDNF and mature BDNF